...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy.
【24h】

The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy.

机译:正电荷或负电荷对光动力疗法中使用的卟啉的被动和离子电渗疗法皮肤渗透的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Meso-tetra-(N-methylpiridinium-4-yl)-porphyrin (TMPyP) and meso-tetra-(4-sulfonatophenyl)-porphyrin (TPPS(4)) are photosensitizing drugs (PS) used in photodynamic therapy (PDT). Based on the fact that these compounds present similar chemical structures but opposite charges at pH levels near physiological conditions, this work aims to evaluate the in vitro and in vivo influence of these electrical charges on the iontophoretic delivery of TMPyP and TPPS(4), attempting to achieve maximum accumulation of PS in skin tissue. The iontophoretic transport of these drugs from a hydrophilic gel was investigated in vitro using porcine ear skin and vertical, flow-through diffusion cells. In vivo experiments using rats were also carried out, and the penetration of the PSs was analyzed by fluorescence microscopy to visualize the manner of how these compounds were distributed in the skin after a short period of iontophoresis application. In vitro, both passive and iontophoretic delivery of the positively charged TMPyP were much greater (20-fold and 67-fold, respectively) than those of the negatively charged TPPS(4). TPPS(4) iontophoresis in vivo increased the fluorescence of the skin only in the very superficial layers. On the other hand, iontophoresis of the positively charged drug expressively increased the rat epidermis and dermis fluorescence, indicating high amounts of this drug throughout the skin layers. Moreover, TMPyP was homogeneously distributed around and into the nuclei of the skin cells, suggesting its potential use in topical PDT.
机译:中四-(N-甲基哌啶-4-基)-卟啉(TMPyP)和中四-(4-磺酰苯基)-卟啉(TPPS(4))是用于光动力疗法(PDT)的光敏药物(PS)。基于这些化合物在生理条件附近的pH值下具有相似的化学结构但电荷相反的事实,这项工作旨在评估这些电荷对TMPyP和TPPS离子电渗传递的体外和体内影响(4)。以获得PS在皮肤组织中的最大积累。使用猪的耳朵皮肤和垂直流通的扩散池,体外研究了这些药物从亲水性凝胶的离子电渗转运。还进行了使用大鼠的体内实验,并通过荧光显微镜对PS的渗透进行了分析,以可视化在短暂的离子电渗疗法后这些化合物在皮肤中的分布方式。在体外,带正电荷的TMPyP的被动和离子电渗疗法都比带负电荷的TPPS更大(分别为20倍和67倍)(4)。体内TPPS(4)离子电渗疗法仅在非常浅的层中增加皮肤的荧光。另一方面,带正电荷的药物的离子电渗疗法可显着增加大鼠表皮和真皮的荧光,表明整个皮肤层均含有大量这种药物。此外,TMPyP均匀分布在皮肤细胞周围和细胞核内,表明其在局部PDT中的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号